1.
Transplant Proc
; 54(6): 1575-1578, 2022.
Article
in English
| MEDLINE | ID: covidwho-1487992
ABSTRACT
We report a case of a heart transplant recipient who presented with a rapidly growing Epstein-Barr virus (EBV)-positive, diffuse large B-cell lymphoma 7 days after receiving the first dose of the ChAdOx1 nCoV-19 vaccine. Because of the atypical radiologic presentation, the initial tentative diagnosis was a mediastinal abscess. This observation indicates a potential risk of EBV reactivation after coronavirus disease 2019 (COVID-19) vaccination, which might lead to or aggravate the presentation of posttransplant lymphoproliferative disorder in transplantation patients. Transplant surgeons should be aware of the potential immunomodulatory effects of the COVID-19 vaccination.
Subject(s)
COVID-19 , ChAdOx1 nCoV-19 , Epstein-Barr Virus Infections , Heart Transplantation , Lymphoproliferative Disorders , Humans , ChAdOx1 nCoV-19/adverse effects , COVID-19/prevention & control , Epstein-Barr Virus Infections/complications , Epstein-Barr Virus Infections/diagnosis , Herpesvirus 4, Human , Lymphoproliferative Disorders/chemically induced , Lymphoproliferative Disorders/diagnosis
2.
Acta Cardiol Sin
; 37(1): 114-116, 2021 Jan.
Article
in English
| MEDLINE | ID: covidwho-1045302